Robert Thomas, chairman of board of directors of Concentric Medical, said: “The positive developments at Concentric over the last several months made the opportunity to participate in this round of financing very attractive to investors. Concentric ended 2008 very successfully, launching multiple new products and expanding its distribution footprint both in the US and in Europe.
“Concentric plans to accelerate market development through diversified technology and additional clinical trials, positioning the company well for 2009 and beyond.”